Role of CYP2E1 in the Progression to NASH
Role of CYP2E1 in the Progression to NASH
批准号:
7901161
负责人:
Mark J Czaja
金额:
$33.02万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-05-15 至 2012-06-30
关键词:
AffectBenignCYP2E1 geneCaspaseCell DeathCellsCessation of lifeChronicCytochrome P450DataDevelopmentDiseaseDown-RegulationEnzymesEventEvolutionFamily memberFatty LiverFundingGlutathioneGoalsHepaticHepatocyteHumanHydrogen PeroxideIn VitroInjuryInsulin ResistanceInvestigationJUN geneLeadLipidsLiverLiver diseasesMediatingMetabolismMitogen-Activated Protein Kinase 3Mitogen-Activated Protein KinasesMolecularOxidantsOxidation-ReductionOxidative StressPathway interactionsPhosphoric Monoester HydrolasesPhosphorylationPrevention strategyProtein IsoformsPublic HealthRALA geneReactive Oxygen SpeciesResistanceRoleSecondary toSignal TransductionSteatohepatitisStimulusTestingTriglyceridesVitamin K 3basedesignendoplasmic reticulum stressfatty acid metabolismfatty acid oxidationin vivoin vivo Modelinsulin sensitivitynon-alcoholic fatty livernonalcoholic steatohepatitisnoveloverexpressionoxidant stresspreventresponsestress-activated protein kinase 1
中文摘要
描述(由申请人提供): 在非酒精性脂肪性肝病(NAFLD)中,启动肝细胞脂质蓄积和从良性脂肪变性进展为肝细胞损伤和慢性肝病的细胞信号尚不清楚。实验性和人类NAFLD均与肝脏氧化应激沿着促氧化细胞色素P450(CYP 1A 1)酶的过度表达有关。我们的一般假设是,这种疾病中的氧化应激改变了促进肝细胞损伤发展的细胞信号级联反应。在过去的资助期内,研究已经确定了氧化应激对调节肝细胞损伤和死亡的促分裂原活化蛋白激酶(MARK)的影响。其他研究表明,CYP 2 E1过表达产生的氧化应激改变肝脏代谢,包括胰岛素敏感性和脂质蓄积。基于这些研究和额外的初步数据,我们的中心假设是,慢性氧化应激过度激活MAPK信号转导是肝脂肪变性和损伤发展的关键机制。我们建议在肝细胞和脂肪变性和氧化应激的体内模型中进行研究,以验证这一假设,这些模型包含在四个具体目标中。首先,我们将检验Bim下调是CYP 2 E1过表达肝细胞抵抗氧化应激死亡的机制这一假设。其次,我们将测试的假设,CYP 2 E1过表达的肝细胞是易受促凋亡JNK/AP- 1过度激活,因为氧化还原依赖性磷酸酶抑制。第三,我们将检验氧化剂诱导的JNK信号介导的胰岛素抵抗促进肝细胞脂肪变性的假设。第四,我们将检验在脂质积累的情况下氧化应激刺激JNK介导的内质网应激引起的细胞死亡的假设。这些研究的最终目标是更好地了解导致脂肪变性和脂肪性肝炎发展的基本细胞机制,以设计预防和治疗人类NAFLD的新策略。与公共卫生的相关性:NAFLD是一种非常普遍的肝病,目前尚无已知的治疗方法。尝试了解这种疾病中脂质积聚和肝损伤的机制对于开发预防和治疗NAFLD的新策略非常重要。
英文摘要
DESCRIPTION (provided by applicant): In nonalcoholic fatty liver disease (NAFLD) the cellular signals that initiate hepatocyte lipid accumulation and progression from benign steatosis to hepatocyte injury and chronic liver disease are unknown. Both experimental and human NAFLD are associated with hepatic oxidative stress along with overexpression of prooxidant cytochrome P450 (CYP) enzymes. Our general hypothesis has been that oxidative stress in this disease alters cell signaling cascades that promote the development of hepatocyte injury. Investigations over the past funding period have defined effects of oxidative stress on mitogen-activated protein kinases (MARK) that regulate hepatocyte injury and death. Other studies have demonstrated that oxidative stress generated by CYP2E1 overexpression alters hepatic metabolism including insulin sensitivity and lipid accumulation. Based on these studies and additional preliminary data, our central hypothesis is that overactivation of MAPK signaling by chronic oxidative stress is a critical mechanism in the development of both hepatic steatosis and injury. We propose to test this hypothesis with studies in hepatocyte and in vivo models of steatosis and oxidative stress that are contained in four specific aims. First, we will test the hypothesis that Bim down regulation is the mechanism by which CYP2E1-overexpressing hepatocytes resist death from oxidant stress. Second, we will test the hypothesis that CYP2E1-overexpressing hepatocytes are susceptible to proapoptotic JNK/AP- 1 overactivation because of redox-dependent phosphatase inhibition. Third, we will test the hypothesis that insulin resistance mediated by oxidant-induced JNK signaling promotes hepatocyte steatosis. Fourth, we will test the hypothesis that oxidative stress in the setting of lipid accumulation stimulates JNK mediated cell death from endoplasmic reticulum stress. The ultimate goal of these investigations is to better understand the basic cellular mechanisms that lead to the development of steatosis and steatohepatitis in order to design new strategies to prevent and treat human NAFLD. Relevance to public health: NAFLD is a very prevalent liver disease which has no known treatment. Attempts to understand the mechanisms of lipid accumulation and liver injury in this disease are important to the development of new strategies for the prevention and treatment of NAFLD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defects in junctional adhesion molecule-A and Intestinal Permeability: Identification of Novel Mechanisms Driving Non-Alcoholic Steatohepatitis
-
批准号:9913994
-
项目类别:
-
资助金额:$47.1万
-
财政年份:2017
-
负责人:Mark J Czaja
-
依托单位:
Regulation of the innate immune response in alcoholic liver disease by autophagy
-
批准号:9250425
-
项目类别:
-
资助金额:$28.41万
-
财政年份:2016
-
负责人:Mark J Czaja
-
依托单位:
Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease
-
批准号:9270797
-
项目类别:
-
资助金额:$18.16万
-
财政年份:2016
-
负责人:Mark J Czaja
-
依托单位:
Regulation of the innate immune response in alcoholic liver disease by autophagy
-
批准号:9115457
-
项目类别:
-
资助金额:$41.39万
-
财政年份:2016
-
负责人:Mark J Czaja
-
依托单位:
Regulation of the innate immune response in alcoholic liver disease by autophagy
-
批准号:9321316
-
项目类别:
-
资助金额:$41.21万
-
财政年份:2016
-
负责人:Mark J Czaja
-
依托单位:
Regulation of the innate immune response in alcoholic liver disease by autophagy
-
批准号:8785146
-
项目类别:
-
资助金额:$45.61万
-
财政年份:2014
-
负责人:Mark J Czaja
-
依托单位:
Regulation of the innate immune response in alcoholic liver disease by autophagy
-
批准号:9135052
-
项目类别:
-
资助金额:$10.65万
-
财政年份:2014
-
负责人:Mark J Czaja
-
依托单位:
Regulation of the innate immune response in alcoholic liver disease by autophagy
-
批准号:8923124
-
项目类别:
-
资助金额:$3.55万
-
财政年份:2014
-
负责人:Mark J Czaja
-
依托单位:
Modulation of Acute Liver Injury
-
批准号:7908374
-
项目类别:
-
资助金额:$9.9万
-
财政年份:2009
-
负责人:Mark J Czaja
-
依托单位:
Role of CYP2E1 in the Progression to NASH
-
批准号:6744719
-
项目类别:
-
资助金额:$32.16万
-
财政年份:2002
-
负责人:Mark J Czaja
-
依托单位:
Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease
-
批准号:8697041
-
项目类别:
-
资助金额:$36.32万
-
财政年份:2002
-
负责人:Mark J Czaja
-
依托单位:
Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease
-
批准号:8369493
-
项目类别:
-
资助金额:$36.32万
-
财政年份:2002
-
负责人:Mark J Czaja
-
依托单位:
Role of CYP2E1 in the Progression to NASH
-
批准号:8112431
-
项目类别:
-
资助金额:$32.69万
-
财政年份:2002
-
负责人:Mark J Czaja
-
依托单位:
Role of CYP2E1 in the Progression to NASH
-
批准号:7020690
-
项目类别:
-
资助金额:$31.41万
-
财政年份:2002
-
负责人:Mark J Czaja
-
依托单位:
Role of CYP2E1 in the Progression to NASH
-
批准号:7650197
-
项目类别:
-
资助金额:$33.35万
-
财政年份:2002
-
负责人:Mark J Czaja
-
依托单位:
Mechanisms of Liver Injury in Nonalcoholic Fatty Liver Disease
-
批准号:8535718
-
项目类别:
-
资助金额:$35.05万
-
财政年份:2002
-
负责人:Mark J Czaja
-
依托单位:
Role of CYP2E1 in the Progression to NASH
-
批准号:7305268
-
项目类别:
-
资助金额:$34.03万
-
财政年份:2002
-
负责人:Mark J Czaja
-
依托单位:
Role of CYP2E1 in the Progression to NASH
-
批准号:7488998
-
项目类别:
-
资助金额:$33.35万
-
财政年份:2002
-
负责人:Mark J Czaja
-
依托单位:
Role of CYP2E1 in the Progression to NASH
-
批准号:6459216
-
项目类别:
-
资助金额:$35.82万
-
财政年份:2002
-
负责人:Mark J Czaja
-
依托单位:
Role of CYP2E1 in the Progression to NASH
-
批准号:6622924
-
项目类别:
-
资助金额:$32.16万
-
财政年份:2002
-
负责人:Mark J Czaja
-
依托单位:
海外基金